New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
10:01 EDTADT, SSTK, BSMX, RGLS, MUSA, KYTH, ICPT, CHTR, ANFI, AMBA, WDAYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ADT Corp. (ADT) initiated with a Buy at Citigroup... Ambarella (AMBA) initiated with a Buy at Deutsche Bank... Amira Nature Foods (ANFI) initiated with a Buy at Deutsche Bank... Charter (CHTR) initiated with an Underweight at Barclays... Intercept Pharmaceuticals (ICPT) initiated with a Buy at Needham... Kythera Biopharmaceuticals (KYTH) initiated with a Neutral at Goldman... Metals USA (MUSA) initiated with an Outperform at Wells Fargo... Regulus Therapeutics (RGLS) initiated with a Buy at Needham... Santander Mexico (BSMX) initiated with a Buy at Citigroup... Shutterstock (SSTK) initiated with a Buy at Jefferies... Workday (WDAY) initiated with a Buy at Canaccord.
News For ADT;AMBA;ANFI;CHTR;ICPT;KYTH;MUSA;RGLS;BSMX;SSTK;WDAY From The Last 14 Days
Check below for free stories on ADT;AMBA;ANFI;CHTR;ICPT;KYTH;MUSA;RGLS;BSMX;SSTK;WDAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
18:35 EDTICPTOn The Fly: After Hours Movers
Subscribe for More Information
16:43 EDTICPTIntercept upgraded to Buy from Neutral at Nomura
Subscribe for More Information
15:53 EDTADTNotable companies reporting before tomorrow's open
Subscribe for More Information
12:47 EDTCHTRCable REIT conversions possible but unlikely, says Wells Fargo
Subscribe for More Information
July 28, 2014
08:24 EDTCHTRTime Warner Cable upgraded to Buy from Hold at Wunderlich
Subscribe for More Information
July 22, 2014
08:25 EDTCHTRComcast reports Q2 operating cash flow up 7% to $5.8B
Subscribe for More Information
July 21, 2014
08:18 EDTRGLSRegulus Therapeutics granted orphan drug designation for RG-012 by FDA
Regulus Therapeutics announced that the FDA has granted orphan drug designation to RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21, as a therapeutic for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. In the near term, Regulus expects to initiate a natural history of disease study to gather further information about the progression of Alport syndrome and to inform future clinical development plans of RG-012, a key program under Regulus' 'Clinical Map Initiative'.
08:07 EDTANFIAmira Nature Foods launches branded products in Ratnadeep supermarkets
Amira Nature Foods announced the launch of Amira branded products in Ratnadeep supermarkets in Hyderabad and Secunderabad, India. Ratnadeep will be offering several Amira products, including Amira Extra Long Grain Basmati Rice, Amira GURU Extra Long Grain Basmati Rice, Amira GOODLENGTH Everyday Basmati Rice, Amira GOODLENGTH Day-to-Day Basmati Rice, Amira Daily Fresh Basmati Rice, and Amira Traditional Namkeens Range.
July 18, 2014
15:04 EDTRGLSWedbush reiterates Outperform rating on Regulus after orphan designation
Subscribe for More Information
11:05 EDTRGLSRegulus Therapeutics treatment of Alport syndrome designated as orphan drug
Subscribe for More Information
July 17, 2014
10:00 EDTCHTROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
09:22 EDTCHTRComcast price target raised to $66 from $62 at Maxim
Maxim raised its price target for Comcast (CMCSA) shares to $66 citing synergies from the Time Warner Cable (TWC), Charter deal. The firm says it values NBC Universal on a 10 times 2015 EBITDA, which it notes is a 14% discount to Fox's (FOXA) proposed bid for Time Warner (TWX), which values Time Warner at 11.6 times. Maxim keeps a Buy rating on Comcast shares.
05:30 EDTCHTRCharter downgraded to Hold from Buy at Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use